Noninvasive assessment of characteristics of novel anti-HER2
Por um escritor misterioso
Descrição
Combined Morphological and Spectroscopic Diagnostic of HER2 Expression in Breast Cancer Tissues Based on Label-Free Surface-Enhanced Raman Scattering
HER2-Low Breast Cancer Can Be Visualized by HER2 PET
Competitive binding assay of Trastuzumab and anti-HER2 scFv to HER2.
Treatment with trastuzumab deruxtecan in patients with HER2-positive breast cancer and brain metastases and/or leptomeningeal disease (ROSET-BM)
IJMS, Free Full-Text
Two- and three-component anti-HER2 vaccines that contain the MFCH401
Cancers, Free Full-Text
Frontiers Application of a Novel 68Ga-HER2 Affibody PET/CT Imaging in Breast Cancer Patients
Persistent Degradation of HER2 Protein by Hybrid nanoPROTAC for Programmed Cell Death
124I-labeled anti-CD147 antibody for noninvasive detection of CD147-positive pan-cancers: construction and preclinical studies
Flow Chart of study. Download Scientific Diagram
Subtyping of metastatic breast cancer based on plasma circulating tumor DNA alterations: An observational, multicentre platform study - eClinicalMedicine
de
por adulto (o preço varia de acordo com o tamanho do grupo)